EC regimen: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of etoposide and carboplatin used for the treatment of [[small cell lung cancer| | {{PAGENAME}} refers to a regimen consisting of etoposide and carboplatin used for the treatment of [[small cell lung cancer|Extensive-stage small cell lung cancer]]. | ||
==Regimen== | ==Regimen== | ||
Line 17: | Line 17: | ||
==Indications== | ==Indications== | ||
*[[small cell lung cancer| | *[[small cell lung cancer|Extensive-stage small cell lung cancer]]. | ||
==References== | ==References== |
Latest revision as of 20:33, 12 March 2015
WikiDoc Resources for EC regimen |
Articles |
---|
Most recent articles on EC regimen |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on EC regimen at Clinical Trials.gov Clinical Trials on EC regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on EC regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on EC regimen Discussion groups on EC regimen Patient Handouts on EC regimen Directions to Hospitals Treating EC regimen Risk calculators and risk factors for EC regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for EC regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:EC Regimen; Etoposide-Carboplatin Regimen
Overview
EC regimen refers to a regimen consisting of etoposide and carboplatin used for the treatment of Extensive-stage small cell lung cancer.
Regimen
EEtoposide
CCarboplatin